We are live on ! Find out more
OGEN icon

Oragenics

12 hedge funds and large institutions have $269K invested in Oragenics in 2024 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 1

150% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 2

20% more funds holding

Funds holding: 1012 (+2)

0.06% more ownership

Funds ownership: 0.08%0.14% (+0.06%)

23% less capital invested

Capital invested by funds: $350K → $269K (-$80.3K)

Holders
12
Holders Change
+2
Holders Change %
+20%
% of All Funds
0.17%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
5
Reduced
2
Closed
1
Calls
Puts
Net Calls
Net Calls Change

OGEN Hedge Fund Activity: Q1 2024 in Review

12 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Oragenics (OGEN) for Q1 2024, worth a combined $269K — down 23% from $350K a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new OGEN positions and 1 closed out — a net gain of 2 holders — while 5 added to existing stakes and 2 trimmed.

The largest buyer was Warberg Asset Management, opening a new position worth an estimated $165K. The largest seller was Fidelity Investments, cutting an estimated $8.29K.

  • 12 institutional investors held Oragenics (OGEN) as of Q1 2024, up from 10 in Q4 2023.
  • Funds reported $269K of Oragenics stock for Q1 2024, down 23% quarter-over-quarter.
  • 3 funds opened new Oragenics positions in Q1 2024 and 1 closed out, a net change of +2 holders.
  • The largest Oragenics buyer in Q1 2024 was Warberg Asset Management, an estimated $165K added.
  • The largest Oragenics seller in Q1 2024 was Fidelity Investments, an estimated $8.29K sold.

Based on aggregated 13F filings for Q1 2024.